骨成長刺激剤の世界市場:製品別(骨成長刺激装置、骨形態形成タンパク質、多血小板血漿)、用途別(脊椎固定術、延性癒合・偽関節骨折、口腔・顎顔面外科、その他)、流通経路別(病院、診療所、在宅医療、その他)、地域別

◆英語タイトル:Global Bone Growth Stimulators Market By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-Rich Plasma) By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Others) By Distribution Channel (Hospitals & Clinics, Home Care and Others) By Region, Industry Analysis and Forecast, 2020 - 2026
◆商品コード:KBV20JN104
◆発行会社(リサーチ会社):KBV Research
◆発行日:2020年4月
◆ページ数:218
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様利用)USD3,600 ⇒換算¥374,400見積依頼/購入/質問フォーム
Global License(法人利用)USD6,048 ⇒換算¥628,992見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKBV Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
KBV Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートは、骨成長刺激剤の世界市場の現状と展望が網羅的に把握できるレポートです。骨成長刺激剤の世界市場について、市場範囲・調査手法、市場動向、製品別(骨成長刺激装置、骨形成タンパク質、多血小板血漿)分析、用途別(脊椎固定術、遷延治癒・偽関節、口腔・顎顔面外科、その他)分析、流通チャネル別(病院・クリニック、在宅医療、その他)分析、地域別分析、企業概要などを把握し、将来性を考察しております。
・市場範囲・調査手法
・市場動向
・骨成長刺激剤の世界市場:製品別(骨成長刺激装置、骨形成タンパク質、多血小板血漿)
・骨成長刺激剤の世界市場:用途別(脊椎固定術、遷延治癒・偽関節、口腔・顎顔面外科、その他)
・骨成長刺激剤の世界市場:流通チャネル別(病院・クリニック、在宅医療、その他)
・骨成長刺激剤の世界市場:地域別
・企業概要
【レポートの概要】

The Global Bone Growth Stimulators Market size is expected to reach $1.7 billion by 2026, rising at a market growth of 7.1% CAGR during the forecast period. Bone growth stimulator devices are medical devices that accelerate the fracture healing cycle in cases of delay or failure. They improve the normal speed of healing by giving patients electrical shocks. Some of the available bone growth stimulators in the market include bone stimulation tools, bone morphogenetic proteins, and platelet-rich plasma. There are three types of bone stimulation devices, including pulsed electromagnetic field devices, capacitive coupling devices, and combined magnetic field devices.
Increasing cases of chronic conditions such as arthritis and osteoporosis would drive market growth. The susceptibility to fractures rises with age, which means that the increasing geriatric population will also contribute to the growth of the global demand for bone growth stimulators. Demographic factors such as increasing average age and global average life expectancy would also have an effect on the overall growth of the market. Diabetes mellitus hinders the body’s normal healing cycle. Growing cases of diabetes along with other medical conditions such as vascular disease, kidney disorders, and obesity would fuel the demand over the forecast timeframe.
With the globally rising infection of Covid-19, the apprehension of the lack of essential life-saving equipment and other vital medical supplies to prevent the spread of this pandemic is also expanding and providing optimum care for the infected. In addition, before pharmacological treatment is established, ventilators serve as a vital treatment preference for COVID-19 patients who may need critical care. In addition, there is an immediate need for rapid acceleration in the manufacturing cycle for a wide range of test kits (antibody tests, self-administration, and others).
Based on Product, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-Rich Plasma. Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Others. Based on Distribution Channel, the market is segmented into Hospitals & Clinics, Home Care and Others. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, Medtronic PLC, Zimmer Biomet Holdings, Inc., Stryker Corporation, Smith & Nephew PLC, Terumo Corporation (Terumo BCT, Inc.), Colfax Corporation (DJO Global, Inc.), Orthofix Medical, Inc., Arthrex, Inc., Bioventus LLC.
Strategies deployed in Bone Growth Stimulators Market
Sep-2019: Bioventus LLC signed an agreement with UnitedHealthcare Employer & Individual commercial plans. Following the agreement, UnitedHealthcare (UHC) commercial plan members would have access to DUROLANE and GELSYN-3 treatments for osteoarthritis (OA) knee pain. Both these treatments are used for osteoarthritis of knee patients who don’t respond to conservative pain treatments such as acetaminophen.
May-2019: Medtronic signed an agreement to acquire Titan Spine, a titanium spine interbody implant and surface technology company. The acquisition aims to strengthen company’s position as a leading innovator in procedural solutions for spine surgery.
Mar-2019: Arthrex extended its distribution agreement with CollPlant, a regenerative medicine company. The companies aimed to distribute VergenixSTR in Europe, the Middle East, India, and certain African countries. VergenixSTR is an injectable gel comprised of cross-linked bioengineered recombinant human type I collagen, rhCollagen, combined with autologous platelet-rich plasma (PRP). The gel accelerates healing in the treatment of tendinopathy, including tennis elbow, rotator cuff, patellar tendon, Achilles tendon, and hand tendons.
Sep-2018: Johnson & Johnson completed the acquisition of Emerging Implant Technologies, a spinal fusion implant developer. The acquisition broadened its subsidiary DePuy Synthes‘ interbody implant portfolio, and EIT’s technology complemented its existing spinal interbody implant segment.
Apr-2018: DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, announced the U.S. launch of the PROTI 360° Integrated Titanium Family of interbody devices. These devices advances care for patients who have degenerative disc disease in the neck and back.
Apr-2018: Medtronic got U.S. Food and Drug administration (FDA) approval for its Infuse Bone Graft in new spine surgery indications. Infuse Bone Graft is used with additional spine implants made of polyetheretherketone (PEEK) in blique lateral interbody fusion (OLIF 25 and OLIF 51) and anterior lumbar interbody fusion (ALIF) procedures at a single level infuse. Bone Graft is used with certain Medtronic interbody fusion devices to treat lumbar degenerative disc disease.
Mar-2018: Orthofix International received the U.S. Food and Drug Administration (FDA) and European CE Mark approvals for its next-generation PhysioStim bone growth stimulators. The PhysioStim devices offer a non-surgical treatment option for patients who have a nonunion fracture to an extremity that has shown no visible signs of healing.
Scope of the Study

Market Segmentation:
By Product
• Bone Growth Stimulation Devices
• Bone Morphogenetic Proteins and
• Platelet-Rich Plasma

By Application
• Spinal Fusion Surgeries
• Delayed Union & Nonunion Bone Fractures
• Oral & Maxillofacial Surgeries and
• Others

By Distribution Channel
• Hospitals & Clinics
• Home Care and
• Others

By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA

Companies Profiled
• Johnson and Johnson
• Medtronic PLC
• Zimmer Biomet Holdings, Inc.
• Stryker Corporation
• Smith & Nephew PLC
• Terumo Corporation (Terumo BCT, Inc.)
• Colfax Corporation (DJO Global, Inc.)
• Orthofix Medical, Inc.
• Arthrex, Inc.
• Bioventus LLC

Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

【レポートの目次】

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Bone Growth Stimulators Market, by Product
1.4.2 Global Bone Growth Stimulators Market, by Application
1.4.3 Global Bone Growth Stimulators Market, by Distribution Channel
1.4.4 Global Bone Growth Stimulators Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Bone Growth Stimulators Market by Product
3.1 Global Bone Growth Stimulation Devices Market by Region
3.2 Global Bone Morphogenetic Proteins Market by Region
3.3 Global Platelet-Rich Plasma Market by Region
Chapter 4. Global Bone Growth Stimulators Market by Application
4.1 Global Spinal Fusion Surgeries Market by Region
4.2 Global Delayed Union & Nonunion Bone Fractures Market by Region
4.3 Global Oral & Maxillofacial Surgeries Market by Region
4.4 Global Other Application Market by Region
Chapter 5. Global Bone Growth Stimulators Market by Distribution Channel
5.1 Global Hospitals & Clinics Market by Region
5.2 Global Home Care Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Bone Growth Stimulators Market by Region
6.1 North America Bone Growth Stimulators Market
6.1.1 North America Bone Growth Stimulators Market by Product
6.1.1.1 North America Bone Growth Stimulation Devices Market by Country
6.1.1.2 North America Bone Morphogenetic Proteins Market by Country
6.1.1.3 North America Platelet-Rich Plasma Market by Country
6.1.2 North America Bone Growth Stimulators Market by Application
6.1.2.1 North America Spinal Fusion Surgeries Market by Country
6.1.2.2 North America Delayed Union & Nonunion Bone Fractures Market by Country
6.1.2.3 North America Oral & Maxillofacial Surgeries Market by Country
6.1.2.4 North America Other Application Market by Country
6.1.3 North America Bone Growth Stimulators Market by Distribution Channel
6.1.3.1 North America Hospitals & Clinics Market by Country
6.1.3.2 North America Home Care Market by Country
6.1.3.3 North America Others Market by Country
6.1.4 North America Bone Growth Stimulators Market by Country
6.1.4.1 US Bone Growth Stimulators Market
6.1.4.1.1 US Bone Growth Stimulators Market by Product
6.1.4.1.2 US Bone Growth Stimulators Market by Application
6.1.4.1.3 US Bone Growth Stimulators Market by Distribution Channel
6.1.4.2 Canada Bone Growth Stimulators Market
6.1.4.2.1 Canada Bone Growth Stimulators Market by Product
6.1.4.2.2 Canada Bone Growth Stimulators Market by Application
6.1.4.2.3 Canada Bone Growth Stimulators Market by Distribution Channel
6.1.4.3 Mexico Bone Growth Stimulators Market
6.1.4.3.1 Mexico Bone Growth Stimulators Market by Product
6.1.4.3.2 Mexico Bone Growth Stimulators Market by Application
6.1.4.3.3 Mexico Bone Growth Stimulators Market by Distribution Channel
6.1.4.4 Rest of North America Bone Growth Stimulators Market
6.1.4.4.1 Rest of North America Bone Growth Stimulators Market by Product
6.1.4.4.2 Rest of North America Bone Growth Stimulators Market by Application
6.1.4.4.3 Rest of North America Bone Growth Stimulators Market by Distribution Channel
6.2 Europe Bone Growth Stimulators Market
6.2.1 Europe Bone Growth Stimulators Market by Product
6.2.1.1 Europe Bone Growth Stimulation Devices Market by Country
6.2.1.2 Europe Bone Morphogenetic Proteins Market by Country
6.2.1.3 Europe Platelet-Rich Plasma Market by Country
6.2.2 Europe Bone Growth Stimulators Market by Application
6.2.2.1 Europe Spinal Fusion Surgeries Market by Country
6.2.2.2 Europe Delayed Union & Nonunion Bone Fractures Market by Country
6.2.2.3 Europe Oral & Maxillofacial Surgeries Market by Country
6.2.2.4 Europe Other Application Market by Country
6.2.3 Europe Bone Growth Stimulators Market by Distribution Channel
6.2.3.1 Europe Hospitals & Clinics Market by Country
6.2.3.2 Europe Home Care Market by Country
6.2.3.3 Europe Others Market by Country
6.2.4 Europe Bone Growth Stimulators Market by Country
6.2.4.1 Germany Bone Growth Stimulators Market
6.2.4.1.1 Germany Bone Growth Stimulators Market by Product
6.2.4.1.2 Germany Bone Growth Stimulators Market by Application
6.2.4.1.3 Germany Bone Growth Stimulators Market by Distribution Channel
6.2.4.2 UK Bone Growth Stimulators Market
6.2.4.2.1 UK Bone Growth Stimulators Market by Product
6.2.4.2.2 UK Bone Growth Stimulators Market by Application
6.2.4.2.3 UK Bone Growth Stimulators Market by Distribution Channel
6.2.4.3 France Bone Growth Stimulators Market
6.2.4.3.1 France Bone Growth Stimulators Market by Product
6.2.4.3.2 France Bone Growth Stimulators Market by Application
6.2.4.3.3 France Bone Growth Stimulators Market by Distribution Channel
6.2.4.4 Russia Bone Growth Stimulators Market
6.2.4.4.1 Russia Bone Growth Stimulators Market by Product
6.2.4.4.2 Russia Bone Growth Stimulators Market by Application
6.2.4.4.3 Russia Bone Growth Stimulators Market by Distribution Channel
6.2.4.5 Spain Bone Growth Stimulators Market
6.2.4.5.1 Spain Bone Growth Stimulators Market by Product
6.2.4.5.2 Spain Bone Growth Stimulators Market by Application
6.2.4.5.3 Spain Bone Growth Stimulators Market by Distribution Channel
6.2.4.6 Italy Bone Growth Stimulators Market
6.2.4.6.1 Italy Bone Growth Stimulators Market by Product
6.2.4.6.2 Italy Bone Growth Stimulators Market by Application
6.2.4.6.3 Italy Bone Growth Stimulators Market by Distribution Channel
6.2.4.7 Rest of Europe Bone Growth Stimulators Market
6.2.4.7.1 Rest of Europe Bone Growth Stimulators Market by Product
6.2.4.7.2 Rest of Europe Bone Growth Stimulators Market by Application
6.2.4.7.3 Rest of Europe Bone Growth Stimulators Market by Distribution Channel
6.3 Asia Pacific Bone Growth Stimulators Market
6.3.1 Asia Pacific Bone Growth Stimulators Market by Product
6.3.1.1 Asia Pacific Bone Growth Stimulation Devices Market by Country
6.3.1.2 Asia Pacific Bone Morphogenetic Proteins Market by Country
6.3.1.3 Asia Pacific Platelet-Rich Plasma Market by Country
6.3.2 Asia Pacific Bone Growth Stimulators Market by Application
6.3.2.1 Asia Pacific Spinal Fusion Surgeries Market by Country
6.3.2.2 Asia Pacific Delayed Union & Nonunion Bone Fractures Market by Country
6.3.2.3 Asia Pacific Oral & Maxillofacial Surgeries Market by Country
6.3.2.4 Asia Pacific Other Application Market by Country
6.3.3 Asia Pacific Bone Growth Stimulators Market by Distribution Channel
6.3.3.1 Asia Pacific Hospitals & Clinics Market by Country
6.3.3.2 Asia Pacific Home Care Market by Country
6.3.3.3 Asia Pacific Others Market by Country
6.3.4 Asia Pacific Bone Growth Stimulators Market by Country
6.3.4.1 China Bone Growth Stimulators Market
6.3.4.1.1 China Bone Growth Stimulators Market by Product
6.3.4.1.2 China Bone Growth Stimulators Market by Application
6.3.4.1.3 China Bone Growth Stimulators Market by Distribution Channel
6.3.4.2 Japan Bone Growth Stimulators Market
6.3.4.2.1 Japan Bone Growth Stimulators Market by Product
6.3.4.2.2 Japan Bone Growth Stimulators Market by Application
6.3.4.2.3 Japan Bone Growth Stimulators Market by Distribution Channel
6.3.4.3 India Bone Growth Stimulators Market
6.3.4.3.1 India Bone Growth Stimulators Market by Product
6.3.4.3.2 India Bone Growth Stimulators Market by Application
6.3.4.3.3 India Bone Growth Stimulators Market by Distribution Channel
6.3.4.4 South Korea Bone Growth Stimulators Market
6.3.4.4.1 South Korea Bone Growth Stimulators Market by Product
6.3.4.4.2 South Korea Bone Growth Stimulators Market by Application
6.3.4.4.3 South Korea Bone Growth Stimulators Market by Distribution Channel
6.3.4.5 Singapore Bone Growth Stimulators Market
6.3.4.5.1 Singapore Bone Growth Stimulators Market by Product
6.3.4.5.2 Singapore Bone Growth Stimulators Market by Application
6.3.4.5.3 Singapore Bone Growth Stimulators Market by Distribution Channel
6.3.4.6 Malaysia Bone Growth Stimulators Market
6.3.4.6.1 Malaysia Bone Growth Stimulators Market by Product
6.3.4.6.2 Malaysia Bone Growth Stimulators Market by Application
6.3.4.6.3 Malaysia Bone Growth Stimulators Market by Distribution Channel
6.3.4.7 Rest of Asia Pacific Bone Growth Stimulators Market
6.3.4.7.1 Rest of Asia Pacific Bone Growth Stimulators Market by Product
6.3.4.7.2 Rest of Asia Pacific Bone Growth Stimulators Market by Application
6.3.4.7.3 Rest of Asia Pacific Bone Growth Stimulators Market by Distribution Channel
6.4 LAMEA Bone Growth Stimulators Market
6.4.1 LAMEA Bone Growth Stimulators Market by Product
6.4.1.1 LAMEA Bone Growth Stimulation Devices Market by Country
6.4.1.2 LAMEA Bone Morphogenetic Proteins Market by Country
6.4.1.3 LAMEA Platelet-Rich Plasma Market by Country
6.4.2 LAMEA Bone Growth Stimulators Market by Application
6.4.2.1 LAMEA Spinal Fusion Surgeries Market by Country
6.4.2.2 LAMEA Delayed Union & Nonunion Bone Fractures Market by Country
6.4.2.3 LAMEA Oral & Maxillofacial Surgeries Market by Country
6.4.2.4 LAMEA Other Application Market by Country
6.4.3 LAMEA Bone Growth Stimulators Market by Distribution Channel
6.4.3.1 LAMEA Hospitals & Clinics Market by Country
6.4.3.2 LAMEA Home Care Market by Country
6.4.3.3 LAMEA Others Market by Country
6.4.4 LAMEA Bone Growth Stimulators Market by Country
6.4.4.1 Brazil Bone Growth Stimulators Market
6.4.4.1.1 Brazil Bone Growth Stimulators Market by Product
6.4.4.1.2 Brazil Bone Growth Stimulators Market by Application
6.4.4.1.3 Brazil Bone Growth Stimulators Market by Distribution Channel
6.4.4.2 Argentina Bone Growth Stimulators Market
6.4.4.2.1 Argentina Bone Growth Stimulators Market by Product
6.4.4.2.2 Argentina Bone Growth Stimulators Market by Application
6.4.4.2.3 Argentina Bone Growth Stimulators Market by Distribution Channel
6.4.4.3 UAE Bone Growth Stimulators Market
6.4.4.3.1 UAE Bone Growth Stimulators Market by Product
6.4.4.3.2 UAE Bone Growth Stimulators Market by Application
6.4.4.3.3 UAE Bone Growth Stimulators Market by Distribution Channel
6.4.4.4 Saudi Arabia Bone Growth Stimulators Market
6.4.4.4.1 Saudi Arabia Bone Growth Stimulators Market by Product
6.4.4.4.2 Saudi Arabia Bone Growth Stimulators Market by Application
6.4.4.4.3 Saudi Arabia Bone Growth Stimulators Market by Distribution Channel
6.4.4.5 South Africa Bone Growth Stimulators Market
6.4.4.5.1 South Africa Bone Growth Stimulators Market by Product
6.4.4.5.2 South Africa Bone Growth Stimulators Market by Application
6.4.4.5.3 South Africa Bone Growth Stimulators Market by Distribution Channel
6.4.4.6 Nigeria Bone Growth Stimulators Market
6.4.4.6.1 Nigeria Bone Growth Stimulators Market by Product
6.4.4.6.2 Nigeria Bone Growth Stimulators Market by Application
6.4.4.6.3 Nigeria Bone Growth Stimulators Market by Distribution Channel
6.4.4.7 Rest of LAMEA Bone Growth Stimulators Market
6.4.4.7.1 Rest of LAMEA Bone Growth Stimulators Market by Product
6.4.4.7.2 Rest of LAMEA Bone Growth Stimulators Market by Application
6.4.4.7.3 Rest of LAMEA Bone Growth Stimulators Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Johnson and Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.1.5.2 Product Launches and Product Expansions:
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Approvals:
7.3 Zimmer Biomet Holdings, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Stryker Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Smith & Nephew PLC
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.6 Terumo Corporation (Terumo BCT, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.7 Colfax Corporation (DJO Global, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Orthofix Medical, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Approvals:
7.9 Arthrex, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.1 Bioventus LLC
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
7.10.2.2 Partnerships, Collaborations, and Agreements:



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[骨成長刺激剤の世界市場:製品別(骨成長刺激装置、骨形態形成タンパク質、多血小板血漿)、用途別(脊椎固定術、延性癒合・偽関節骨折、口腔・顎顔面外科、その他)、流通経路別(病院、診療所、在宅医療、その他)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆